Our news

Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]

Mayo Clinic Clinical trials advance medicine, but the National Institutes of Health says that more than half of studies are unable to recruit or retain the necessary research participants, which can exacerbate health disparities. However, in recent years, digital technologies have helped trials become more accessible and inclusive. Clinical trials are moving out of traditional research facilities and […]

Applied Clinical Trials As with another oft-mentioned path, the road leading to regulatory approval is paved with good intentions. Clinical trials testing molecules once deemed to be of financial and medical value can, metaphorically at least, be found stacked up outside the regulator’s door. The many factors that halt a trial’s successful progress are a […]

Applied Clinical Trials Contract research organizations (CROs) often find themselves in the challenging situation of delivering on sponsors’ ambitions. To deepen the understanding of CROs’ experiences, leaders from Bioforum, KCR, Syneos Health, and Veeva came together to share insights on the state of digital clinical trials and how the industry will evolve over the next […]